CCEL

Cryo-Cell International, Inc.

5.60 USD

Last updated Dec 10, 01:03 UTC

Yesterday HIGH

$6.47

Yesterday LOW

$5.96

52w HIGH

$7.25

52w LOW

$2.69

EPS

0.08

PE

70.00

Next Earnings

Feb 27, 2024

Overview News Government Trades

Cryo-Cell International, Inc. stock is up 7.9% since 30 days ago. The next earnings date is Feb 27, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 34.48% of the previous 28 December’s closed higher than November.

Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells. The company also manufactures and sells PrepaCyte CB processing system. It stores approximately 500,000 cord blood and cord tissue stem cells worldwide.

Stock Exchange

OTC

Sector

Services

Industry

Healthcare

Headquarters

-

Website

cryo-cell.com

Benzinga Newsdesk

Thu Oct 12, 2023

Cryo-Cell International Q3 EPS $0.08 Vs. $0.06 Prior Year, Sales $7.87M Beat $7.77M Estimate

Cryo-Cell International (NASDAQ:CCEL) reported quarterly earnings of $0.08 per share. This is a 33.33 percent increase over earnings of $0.06 per share from the same period last year. The company reported quarterly sales
Benzinga Newsdesk

Fri Jul 14, 2023

Cryo-Cell International Q2 EPS $0.03 Beats $(0.08) Estimate, Sales $7.77M Inline

Cryo-Cell International (NASDAQ:CCEL) reported quarterly earnings of $0.03 per share which beat the analyst consensus estimate of $(0.08) by 137.5 percent. This is a 57.14 percent decrease over earnings of $0.07 per
Benzinga Insights

Wed Apr 26, 2023

12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights

Mon Apr 24, 2023

Looking Into Cryo-Cell International's Return On Capital Employed
Michael Horton

Fri Apr 21, 2023

Cryo-Cell International Q1 EPS $0.09 Beats $0.01 Estimate, Sales $7.82M Beat $7.41M Estimate

Cryo-Cell International (NASDAQ:CCEL) reported quarterly earnings of $0.09 per share which beat the analyst consensus estimate of $0.01 by 800 percent. This is a 10 percent decrease over earnings of $0.10 per share from
Happy Mohamed

Tue Feb 28, 2023

Cryo-Cell Reports Financial Results For Fiscal Year Ended November 30, 2022; EPS $0.33 Vs $0.25 YoY; Revenues Of $30.3M Vs $28.9M YoY

Revenue Consolidated revenues for fiscal 2022 were $30.3 million compared to $28.9 million for fiscal 2021. The revenues for fiscal 2022 consisted of $29.8 million in processing and storage
Michael Horton

Fri Oct 14, 2022

Cryo-Cell International Q3 EPS $0.06 Down From $0.10 YoY, Sales $7.70M Up From $7.50M YoY

Cryo-Cell International (NASDAQ:CCEL) reported quarterly earnings of $0.06 per share. This is a 40 percent decrease over earnings of $0.10 per share from the same period last year. The company reported $7.70 million in
Lisa Levin

Wed Oct 5, 2022

Why KalVista Pharmaceuticals Shares Are Trading Lower By 59%; Here Are 89 Biggest Movers From Yesterday

Losers
Benzinga Insights

Tue Oct 4, 2022

12 Health Care Stocks Moving In Tuesday's Intraday Session

Gainers
Lisa Levin

Wed Sep 7, 2022

Why Korn Ferry Is Trading Lower By Over 8%, Here Are 40 Stocks Moving In Wednesday's Mid-Day Session

Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) jumped 64% to $0.1199. Allena Pharmaceuticals shares dipped over 30% on Tuesday after the company announced it has filed for bankruptcy.